The novel therapy of tirzepatide peptide represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects multiple pathways – GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) – resulting in improved blood sugar management and possible weight reduction. Researchers are stud